Jakarta, CNBC Indonesia – Pharmaceutical issuers’ shares This morning, Tuesday (07/28/2020) collapsed again, after last week pharmaceutical stocks shot up hundreds of percent due to the sentiment of the corona vaccine that had arrived in Indonesia.
The fall of pharmaceutical shares occurred a day after the Indonesia Stock Exchange (IDX) set some shares that move in this sector as shares that move unnaturally alias UMA (unusual market activity).
This decline itself is the second day that pharmaceutical companies have fallen to the level auto reject down aka ARB. Following are the movements of pharmaceutical issuers during the day this.
The stock price of two Bio business partners Farm, PT Indofarma Tbk (INAF) and PT Kimia Farm Tbk (KAEF) return plummeted touch level auto reject under (WITHB) on morning trading this.
Stock prices INAF down7% to the price level of Rp 2.260/unitwhile KAEF plummeted 6.67% in price level of Rp 2.380/unit. A subsidiary of KAEF, PT Phapros Tbk (PEHA) was also observed to sink 6.95% to a price level of Rp 1,540 / unit
Known ownership of PT Bio Farm in stock KAEF 90.03% and the remaining 9.97% public, while the ownership of PT Bio Farm in stock INAF is 80.68%, 13.91% owned by AsabriThe remaining 5.4% is owned by the public.
Furthermore, pharmaceutical stock issuers, PT Pyridam Farm Tbk (PYFA) anjlok 6.82% to the level of Rp 1.025/ unit after foreign got a chance entering quite large through market negotiations in this issuer.
Meanwhile the largest market capitalized pharmaceutical stock in Indonesia PT Kalbe Farm Tbk (KLBF) corrected by 0.65% to the price level Rp 1.540/unit.
Last week’s rise in pharmaceutical stocks came after Special Staff of the Minister of BUMN Arya Sinulingga confirm that the vaccine candidate Covid-19 of Sinovac Biotech has arrived in Indonesia and is now in the process of phase three clinical trials at Bio Farm.
“We do hope that after clinical trials and tests will be produced later in Indonesia. Some countries indeed invite us to work together,” he said. Arya Sinulingga in a virtual press conference on Monday (7/20/2020).
Chairperson of the Handling Committee Covid-19 and the National Economic Recovery Erick Thohir say vaccine test Covid-19 is almost final and ready for distribution in Indonesia in early 202I. But he asked the public to remain disciplined.
Meanwhile the President either Widodo (Jokowi) Last Tuesday (7/21/2020) received a vaccine clinical trial team Covid-19 from the University’s Faculty of Medicine Padjajaran, Bio Farm and Body Supervisor Medicine and Food (BPOM) at Istana Merdeka.
During the meeting Jokowi said Indonesia would conduct a vaccine clinical trial Covid-19 phase three involving 1,630 volunteers and the results will be compared with the results of the same clinical trials in various countries.
(trp/trp)
–
